Asymmetrex Approved to Conduct an ASTM Interlaboratory Evaluation of Its AlphaSTEM Test™ Technology as a Standard for Counting Therapeutic Adult Tissue Stem Cells

On May 16, at the ASTM International May Committee Meeting in Denver, Colorado, Massachusetts stem cell biotechnology company Asymmetrex received unanimous approval of its proposal for an interlaboratory evaluation of the company’s AlphaSTEM Test™ technology for counting therapeutic adult tissue stem cells. Highlighting the importance of the approval, a day earlier, the Standards Coordinating Body

May 21, 2019

Asymmetrex Presents Proposal for ASTM Interlaboratory Evaluation of AlphaSTEM Test™ Technology Towards Establishing A Standard for Counting Therapeutic Stem Cells

Today, May 16, at the ASTM International May Committee Meeting in Denver, Colorado, Massachusetts stem cell biotechnology company Asymmetrex will present a proposal for an interlaboratory evaluation of the company’s AlphaSTEM Test™. Approval of this ASTM evaluation will be an important step in Asymmetrex’s plan to establish the AlphaSTEM Test™ as a stem cell industry

May 16, 2019

Understand Stem Cell Tools and How They Are Used

What is cryopreservation? Preserving by freezing, usually at extremely low temperatures (e.g., ≤ 130^oC). What is cryopreservation of cells? Freezing cells in a manner in which they remain viable after thawing. What is a blood spinning machine used for? To separate the cellular components of unclotted blood (red blood cells and white blood cells) from

October 10, 2018

Adult Stem Cell Engineering

Asymmetrex’s SACK Technology Makes Adult Tissue Stem Cell Genetic Engineering a Simple Reality By providing highly enriched populations of tissue-specific adult stem cells, Asymmetrex’s SACK technology makes direct adult tissue stem cell engineering practical for the first time.  With SACK agent supplementation, cultures of SACK strains have stem cell fractions that range from 20% to

September 14, 2018

Mouse | Rat | Human Tissue Cells

Regenerative Medicine is Awaiting the Mass Production of Therapeutic Adult Tissue Stem Cells that is Possible with Asymmetrex’s SACK Technology and Use of Mouse | Rat | Human Tissue Cells I. SACK Manufacturing of Human Adult Tissue Stem Cells Asymmetrex has a vision of developing SACK manufacturing-scale processes for mass production of human tissue stem

September 14, 2018

What is Cell Counting?

No matter what the specific discipline, the best scientific research strives to be quantitative. Throughout research and practice in science, engineering, and medicine, measuring the focus of investigation is an implicit essential principle. In cell biology, this crucial application is cell counting. How are cell counts calculated? In all cell counting methods, three general steps

September 12, 2018

Asymmetrex Proposes “Stemgene Therapy”

The founder and director of stem cell biotechnology company Asymmetrex, James L. Sherley, M.D., Ph.D., continues to lead the company’s public service mission of disseminating timely scientific information on the qualities of tissue stem cells and their use for medical therapies. Most recently, in a July 20 invited essay posted on the Oncology webpage of

July 24, 2018

Greater Numbers of Therapeutic Adult Tissue Stem Cells at Reduced Cost

For many years, progress in stem cell medicine has been held back because of a lack of effective and efficient methods for the manufacture of therapeutic adult tissue stem cells. Massachusetts stem cell biotechnology company Asymmetrex announces this week that it now offers a new contract service that can help suppliers of therapeutic adult tissue

August 29, 2017

Introducing First Quality Control Test for Therapeutic Tissue Stem Cells

On March 8-9 in Boston, stem cell medicine biotechnology start-up Asymmetrex led attendees at the 6th Annual Clinical Trials Supply New England 2017 conference in discussions about the need for quality controls for the supply of tissue stem cells used for treatments in either FDA-approved clinical trials or unregulated private stem cell clinics. Though these

March 14, 2017

AlphaSTEM Test: Established to Be a Leading Interest for Regenerative Medicine

Boston’s stem cell medicine biotechnology start-up Asymmetrex is beginning 2017 with exciting news for its recently launched contract service for counting adult tissue stem cells. The company’s webinar, produced with the international regenerative medicine social media network RegMedNet to describe Asymmetrex’s new counting technology and its applications, was 4th among the 10 most popular content

January 10, 2017

Next Page »